One dose of Sanofi Pasteur's H1N1 vaccine fails to provide children with seroprotection
19 October 2009
Elizabeth Sukkar
Sanofi-Pasteur's US approved pandemic H1N1 influenza vaccine does not provide children with seroprotection after one dose, show interim data from a US paediatric trial. Further results are awaited for the effect of the two-dose schedule, which is the basis of the product's licence.
The first data...
Please Login to read the full article.
19 October 2009
Elizabeth Sukkar
The first data...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Universal flu vaccine BiondVax goes robustly beyond first phase II trial
- Pharma can sign up to help in the next flu pandemic, but may worry about IP rights
- US expanded label for UCB anti-epileptic 'a reflection of patient centric culture'
- US Capitol Capsule: Will sequestration be a better outcome for biopharma?
FEATURES
Other Informa Features
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
